Literature DB >> 28687523

TDP-43 in the spectrum of MND-FTLD pathologies.

Lanier Heyburn1, Charbel E-H Moussa2.   

Abstract

The relationship between RNA-binding proteins, particularly TAR DNA binding protein 43 (TDP-43), and neurodegeneration is an important area of research. TDP-43 is involved in so many cellular processes that perturbation of protein homeostasis can lead to countless downstream effects. Understanding what leads to this disease-related protein imbalance and the resulting cellular and molecular effects will help to develop targets for disease intervention, whether it be prevention of protein accumulation, or addressing a secondary effect of protein accumulation. Here we review the current literature of TDP-43 and TDP-43 pathologies, the effects of TDP-43 overexpression and disruption of synaptic proteins through its binding of messenger RNA, leading to synaptic dysfunction. This review highlights some of the still-limited knowledge of the protein TDP-43 and how it can contribute to disease.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28687523      PMCID: PMC5581706          DOI: 10.1016/j.mcn.2017.07.001

Source DB:  PubMed          Journal:  Mol Cell Neurosci        ISSN: 1044-7431            Impact factor:   4.314


  122 in total

1.  Stress granule assembly is mediated by prion-like aggregation of TIA-1.

Authors:  Natalie Gilks; Nancy Kedersha; Maranatha Ayodele; Lily Shen; Georg Stoecklin; Laura M Dember; Paul Anderson
Journal:  Mol Biol Cell       Date:  2004-09-15       Impact factor: 4.138

2.  Phosphorylation promotes neurotoxicity in a Caenorhabditis elegans model of TDP-43 proteinopathy.

Authors:  Nicole F Liachko; Chris R Guthrie; Brian C Kraemer
Journal:  J Neurosci       Date:  2010-12-01       Impact factor: 6.167

3.  Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis.

Authors:  J D Rothstein; M Van Kammen; A I Levey; L J Martin; R W Kuncl
Journal:  Ann Neurol       Date:  1995-07       Impact factor: 10.422

Review 4.  TDP-43 functions and pathogenic mechanisms implicated in TDP-43 proteinopathies.

Authors:  Todd J Cohen; Virginia M Y Lee; John Q Trojanowski
Journal:  Trends Mol Med       Date:  2011-07-23       Impact factor: 11.951

5.  Chronological requirements of TDP-43 function in synaptic organization and locomotive control.

Authors:  Giulia Romano; Raffaella Klima; Emanuele Buratti; Patrik Verstreken; Francisco E Baralle; Fabian Feiguin
Journal:  Neurobiol Dis       Date:  2014-08-01       Impact factor: 5.996

6.  ALS Mutations Disrupt Phase Separation Mediated by α-Helical Structure in the TDP-43 Low-Complexity C-Terminal Domain.

Authors:  Alexander E Conicella; Gül H Zerze; Jeetain Mittal; Nicolas L Fawzi
Journal:  Structure       Date:  2016-08-18       Impact factor: 5.006

7.  Co-morbidity of TDP-43 proteinopathy in Lewy body related diseases.

Authors:  Hanae Nakashima-Yasuda; Kunihiro Uryu; John Robinson; Sharon X Xie; Howard Hurtig; John E Duda; Steven E Arnold; Andrew Siderowf; Murray Grossman; James B Leverenz; Randy Woltjer; Oscar L Lopez; Ronald Hamilton; Debby W Tsuang; Douglas Galasko; Eliezer Masliah; Jeffrey Kaye; Christopher M Clark; Thomas J Montine; Virginia M-Y Lee; John Q Trojanowski
Journal:  Acta Neuropathol       Date:  2007-07-25       Impact factor: 17.088

8.  Elevated expression of TDP-43 in the forebrain of mice is sufficient to cause neurological and pathological phenotypes mimicking FTLD-U.

Authors:  Kuen-Jer Tsai; Chun-Hung Yang; Yen-Hsin Fang; Kuan-Hung Cho; Wei-Lin Chien; Wei-Ting Wang; Tzu-Wei Wu; Ching-Po Lin; Wen-Mei Fu; Che-Kun James Shen
Journal:  J Exp Med       Date:  2010-07-26       Impact factor: 14.307

9.  The ALS/FTLD-related RNA-binding proteins TDP-43 and FUS have common downstream RNA targets in cortical neurons.

Authors:  Daiyu Honda; Shinsuke Ishigaki; Yohei Iguchi; Yusuke Fujioka; Tsuyoshi Udagawa; Akio Masuda; Kinji Ohno; Masahisa Katsuno; Gen Sobue
Journal:  FEBS Open Bio       Date:  2013-11-20       Impact factor: 2.693

Review 10.  Astrocytes and Microglia as Non-cell Autonomous Players in the Pathogenesis of ALS.

Authors:  Junghee Lee; Seung Jae Hyeon; Hyeonjoo Im; Hyun Ryu; Yunha Kim; Hoon Ryu
Journal:  Exp Neurobiol       Date:  2016-10-20       Impact factor: 3.261

View more
  5 in total

Review 1.  DNA Damage, Defective DNA Repair, and Neurodegeneration in Amyotrophic Lateral Sclerosis.

Authors:  Anna Konopka; Julie D Atkin
Journal:  Front Aging Neurosci       Date:  2022-04-27       Impact factor: 5.702

Review 2.  SMN regulation in SMA and in response to stress: new paradigms and therapeutic possibilities.

Authors:  Catherine E Dominguez; David Cunningham; Dawn S Chandler
Journal:  Hum Genet       Date:  2017-08-29       Impact factor: 4.132

3.  Behavioural and Cognitive Changes in Neurodegenerative Diseases and Brain Injury.

Authors:  Francesca Trojsi; Foteini Christidi; Raffaella Migliaccio; Hernando Santamaría-García; Gabriella Santangelo
Journal:  Behav Neurol       Date:  2018-07-25       Impact factor: 3.342

4.  Identification of multiple TAR DNA binding protein retropseudogene lineages during the evolution of primates.

Authors:  Juan C Opazo; Kattina Zavala; Luis Vargas-Chacoff; Francisco J Morera; Gonzalo A Mardones
Journal:  Sci Rep       Date:  2022-03-09       Impact factor: 4.379

5.  Ataxin-2 Dysregulation Triggers a Compensatory Fragile X Mental Retardation Protein Decrease in Drosophila C4da Neurons.

Authors:  In Jun Cha; Davin Lee; Sung Soon Park; Chang Geon Chung; Seung Yeon Kim; Min Gu Jo; Seung Yeol Kim; Byung-Hoon Lee; Young-Sam Lee; Sung Bae Lee
Journal:  Mol Cells       Date:  2020-10-31       Impact factor: 5.034

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.